$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Comparison of prasugrel versus clopidogrel in Korean patients with acute myocardial infarction undergoing successful revascularization 원문보기

Journal of cardiology, v.71 no.1, 2018년, pp.36 - 43  

Park, Keun-Ho (Chosun University Hospital, Gwangju, Republic of Korea) ,  Jeong, Myung Ho (Chonnam National University Hospital, Gwangju, Republic of Korea) ,  Kim, Hyun Kuk (Chosun University Hospital, Gwangju, Republic of Korea) ,  Ahn, Tae Hoon (Gachon University Gil Medical Center, Incheon, Republic of Korea) ,  Seung, Ki Bae (The Catholic University of Korea Seoul St. Mary's Hospital, Seoul, Republic of Korea) ,  Oh, Dong Joo (Korea University Guro Hospital, Seoul, Republic of Korea) ,  Choi, Dong-Joo (Seoul National University Bundang Hospital, Seoul, Republic of Korea) ,  Kim, Hyo-Soo (Seoul National University Hospital, Seoul, Republic of Korea) ,  Gwon, Hyeon Cheol (Sungkyunkwan University Samsung Medical Center, Seoul, Republic of Korea) ,  Seong, In Whan (Chungnam National University Hospital, Daejeon, Republic of Korea) ,  Hwang, Kyung Kuk (Chungbuk National University Hospital, Cheongju, Republic of Korea) ,  Chae, Shung Chull (Kyungpook National University Hospital, Daegu, Republic of Korea) ,  Kim, Kwon-Bae (Keimyung University Dongsan Medical Center, Daegu, Republic of Korea) ,  Kim, Young Jo (Yeungnam University Hospital, Daegu, Republic of Korea) ,  Cha, Kwang Soo (Pusan National University Hospital, Busan, Republic of Korea) ,  Oh, Seok Kyu (Wo) ,  Chae, Jei Keon

Abstract AI-Helper 아이콘AI-Helper

Conclusions: Our study shows that the recommended dose of prasugrel had significantly higher in hospital bleeding complications without reducing ischemic events compared with clopidogrel. However, further large-scale, long-term, randomized clinical trials are required to accurately assess the effica...

주제어

참고문헌 (27)

  1. N Engl J Med Leon 339 1665 1998 10.1056/NEJM199812033392303 A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators 

  2. N Engl J Med Yusuf 345 494 2001 10.1056/NEJMoa010746 Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial I. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation 

  3. Heart Clappers 93 258 2007 10.1136/hrt.2005.071209 Antiplatelet treatment for coronary heart disease 

  4. JAMA Eagle 291 2727 2004 10.1001/jama.291.22.2727 A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry 

  5. JAMA Steg 297 1197 2007 10.1001/jama.297.11.1197 One-year cardiovascular event rates in outpatients with atherothrombosis 

  6. Eur Heart J Roffi 37 267 2016 10.1093/eurheartj/ehv320 

  7. Circulation Levine 134 e123 2016 10.1161/CIR.0000000000000404 

  8. Cardiovasc Drug Rev Jakubowski 25 357 2007 10.1111/j.1527-3466.2007.00027.x Prasugrel: a novel thienopyridine antiplatelet agent. A review of preclinical and clinical studies and the mechanistic basis for its distinct antiplatelet profile 

  9. J Cardiol Park 63 99 2014 10.1016/j.jjcc.2013.07.004 Comparison of peri-procedural platelet inhibition with prasugrel versus adjunctive cilostazol to dual anti-platelet therapy in patients with ST segment elevation myocardial infarction 

  10. J Cardiol Kubo 69 436 2017 10.1016/j.jjcc.2016.04.005 Reduction of in-stent thrombus immediately after percutaneous coronary intervention by pretreatment with prasugrel compared with clopidogrel: an optical coherence tomography study 

  11. Am J Cardiol Wiviott 108 905 2011 10.1016/j.amjcard.2011.05.020 Efficacy and safety of intensive antiplatelet therapy with prasugrel from TRITON-TIMI 38 in a core clinical cohort defined by worldwide regulatory agencies 

  12. Circ J Kim 80 1427 2016 10.1253/circj.CJ-16-0061 Multicenter cohort study of acute myocardial infarction in Korea-interim analysis of the Korea Acute Myocardial Infarction Registry-National Institutes of Health Registry 

  13. Circulation Mehran 123 2736 2011 10.1161/CIRCULATIONAHA.110.009449 Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium 

  14. Multivariate Behav Res Austin 46 399 2011 10.1080/00273171.2011.568786 An introduction to propensity score methods for reducing the effects of confounding in observational studies 

  15. Eur Heart J Patrono 32 2922 2011 10.1093/eurheartj/ehr373 Antiplatelet agents for the treatment and prevention of atherothrombosis 

  16. Nat Rev Cardiol Levine 11 597 2014 10.1038/nrcardio.2014.104 Expert consensus document: World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI 

  17. J Am Coll Cardiol Shen 50 309 2007 10.1016/j.jacc.2007.01.098 Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation 

  18. Thromb Haemost Ma 107 1014 2012 10.1160/TH11-04-0214 Current antithrombotic treatment in East Asia: some perspectives on anticoagulation and antiplatelet therapy 

  19. Circ J Goto 79 2452 2015 10.1253/circj.CJ-15-0112 Ticagrelor vs. clopidogrel in Japanese, Korean and Taiwanese patients with acute coronary syndrome - randomized, double-blind, phase III PHILO study 

  20. Int J Cardiol Park 215 193 2016 10.1016/j.ijcard.2016.04.044 Comparison of short-term clinical outcomes between ticagrelor versus clopidogrel in patients with acute myocardial infarction undergoing successful revascularization; from Korea Acute Myocardial Infarction Registry-National Institute of Health 

  21. J Am Coll Cardiol O’Donoghue 54 678 2009 10.1016/j.jacc.2009.05.025 

  22. Circ J Saito 78 1684 2014 10.1253/circj.CJ-13-1482 Efficacy and safety of adjusted-dose prasugrel compared with clopidogrel in Japanese patients with acute coronary syndrome: the PRASFIT-ACS study 

  23. Circ J Saito 79 1928 2015 10.1253/circj.CJ-15-0276 Impact of arterial access route on bleeding complications in Japanese patients undergoing percutaneous coronary intervention - insight from the PRASFIT Trial 

  24. J Am Coll Cardiol Doyle 53 2019 2009 10.1016/j.jacc.2008.12.073 Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice 

  25. Circ Cardiovasc Interv Iqbal 7 456 2014 10.1161/CIRCINTERVENTIONS.114.001314 Radial versus femoral access is associated with reduced complications and mortality in patients with non-ST-segment-elevation myocardial infarction: an observational cohort study of 10,095 patients 

  26. Lancet Valgimigli 385 2465 2015 10.1016/S0140-6736(15)60292-6 Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial 

  27. J Cardiol Numasawa 69 272 2017 10.1016/j.jjcc.2016.05.003 Incidence and predictors of bleeding complications after percutaneous coronary intervention 

LOADING...

관련 콘텐츠

오픈액세스(OA) 유형

BRONZE

출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문

이 논문과 함께 이용한 콘텐츠

유발과제정보 저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로